Concepedia

R.T. Elaidi

RE

3

Publications

63

Citations

3

H-Index

2015

Active since

Affiliations

Inserm(Current)

Université Paris Cité

KU Leuven

Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie

La Ligue Contre le Cancer

R.T. Elaidi is an author at Inserm specializing in cancer therapeutics, urology, and radiation oncology.

Top concepts

Publications per year

2015–2020

3

Publications

3

LBA25 Results from the phase II biomarker driven trial with nivolumab (N) and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer (m-ccRCC) patients (pts): The BIONIKK trial

Yann Vano, R.T. Elaidi, Mostefa Bennamoun et al. · Annals of Oncology · 2020 · 29 citations

, , +7

RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs

Benoit Beuselinck, J. Jean-Baptiste, Gabrielle Couchy et al. · British Journal of Cancer · 2015 · 24 citations · Full text

Tumor molecular characteristics in patients (pts) with international metastatic renal cell carcinoma database consortium (IMDC) good (G) and intermediate/poor (I/P) risk

Benoit Beuselinck, Annelies Verbiest, Gabrielle Couchy et al. · Annals of Oncology · 2018 · 10 citations · Full text

Rows per page

1–3 of 3